Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
about
Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFInhibition of Nodal suppresses angiogenesis and growth of human gliomasA novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesThe Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cellsDominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survivalRegulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alphaInvasion and metastasis in pancreatic cancerPathways for aberrant angiogenesis in pancreatic cancerA novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assayRole of targeted therapy in metastatic colorectal cancerAngiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide regionTranscription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptorsRoles of platelet factor 4 in hematopoiesis and angiogenesisFirst-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumorsMiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1αVascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the ratVEGF links hippocampal activity with neurogenesis, learning and memoryInhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growthDistinct protein kinase C isoforms mediate regulation of vascular endothelial growth factor expression by A2A adenosine receptor activation and phorbol esters in pheochromocytoma PC12 cellsNitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansionAngiogenic growth factors in neural embryogenesis and neoplasiaDifferential effects of a soluble or immobilized VEGFR-binding peptide.Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastomaImaging biomarkers for antiangiogenic therapy in malignant gliomas.HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity.Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis.Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants.Concave pit-containing scaffold surfaces improve stem cell-derived osteoblast performance and lead to significant bone tissue formation.Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.Targetting VEGF in anti-angiogenic and anti-tumour therapy: where are we now?Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Strategy of liver-directed gene therapy: present status and future prospects.The vascular endothelial growth factor family: signalling for vascular development.The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.Growth factor signaling pathways in vascular development.Accessing key steps of human tumor progression in vivo by using an avian embryo model.
P2860
Q22253478-87FFE3E1-02FC-4DA7-A5A5-B2798EBA7EE8Q24309876-33CE0EAE-AE3C-4468-BCAC-B31E4D54DFD1Q24336293-C394B0C5-639C-4B2E-8E4E-7DD4DE2ECA38Q24532025-D13FD14C-692B-4C52-B84F-F10A518C0C61Q24546291-786D44A9-7A6F-4601-BF03-6DFBA4655B2AQ24610199-6688E270-3D3D-4966-BD13-71A27A6BBE42Q24800065-04890F6B-4E47-4B71-8FC1-7BCA2BA6C31DQ24800215-918BA795-B7E1-4785-B183-76A7DDF1ACF3Q24801625-840AC543-217D-4125-B425-3DA86098C281Q28068817-0DCF7FDE-7CAA-46FA-A6C1-367AE8445AADQ28205770-79786A44-CC4E-4684-9FC5-468C9D530102Q28236615-EF27055C-B385-423B-9D68-2C7AB21EA0E9Q28294538-C23BA97F-5A20-4570-AFB9-D185E46B18FEQ28537681-2408082F-C98C-4260-9C23-4A7F988C036CQ28542821-8307BCA7-8B4E-41A7-943B-3CEA37B54D97Q28570072-4D38422A-6D02-4105-9369-490FACDD6ADAQ28578381-951F329E-59C7-4EBC-B3C6-26B9899B6684Q28578750-D9023084-F417-4E45-BB01-EF866AE9E4ACQ28582266-3E9DCF65-E3A5-4579-88E5-EDBBBBDD0405Q30008769-8DFBCD65-2CB1-4E5E-A44C-F468127669C8Q30422525-87FB4F38-B6D8-4B69-81A6-0CFD1FB54E2CQ30498863-58AA1555-34A2-4B8B-BF20-8527720C0FD9Q30524090-A01CAC41-5675-4080-97E9-30842C4843A7Q30636178-9C139594-D7F0-4D10-8210-59F90800714AQ30661157-17E3E5D1-8A4B-4D28-9F1D-9D605F06ACEFQ30764736-E39017F9-1A40-4366-A962-D123A6462C80Q30828692-67FB664A-9207-4A36-A3D5-E7F27F98BF1EQ30864689-B6195C16-DFC1-444F-97CF-36C929B9390DQ32005883-425FC357-E67A-4FD2-A28A-927549EDD045Q33286817-A3DE02D6-EF74-4887-9B87-3C98878E1483Q33397569-F5219B77-2F51-47ED-827C-2C21526484F2Q33416917-76E09850-CDF3-454C-BB3B-0640BAFB62A2Q33630409-06B09555-02F4-4A64-9809-ACDEC66E635AQ33632180-EFB57C53-F959-4463-80C8-9E1393752577Q33633839-9D1066B9-9C23-40E1-A6E7-199D44513644Q33718826-FF47FD1B-A232-49C3-8F43-49B547CFD238Q33737967-778AE3AB-8150-4133-B4C7-53E26EA9A18FQ33794860-457CE759-E513-442B-B2B0-F11D17262E00Q33814336-F45A6BEE-79A0-48B8-856C-100A270E9FE5Q33818411-C18E084A-8494-41EA-88B1-7744392CD050
P2860
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
@en
type
label
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
@en
prefLabel
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
@en
P2093
P356
P1433
P1476
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
@en
P2093
P2888
P304
P356
10.1038/367576A0
P407
P577
1994-02-01T00:00:00Z
P6179
1016282476